A institutional review board classifies biomedical research protocols into three oversight streams based on two parameters: Participant Risk Level (High, Medium, or Low) and Data Integrity Score (, where ). The classification is governed by the following strict hierarchy of rules:
1. Full Board Audit: Assigned if the protocol has a High Participant Risk Level OR a Data Integrity Score of .
2. Expedited Committee Review: Assigned if the protocol does not require a Full Board Audit AND meets at least one of the following conditions: Medium Participant Risk Level OR a Data Integrity Score in the range .
3. Administrative Exemption: Assigned to any protocol that does not meet the criteria for either Full Board Audit or Expedited Committee Review (i.e., Low Participant Risk Level AND ).
Four trial protocols are currently under review:
- Protocol 101: Medium Participant Risk;
- Protocol 102: High Participant Risk;
- Protocol 103: Low Participant Risk;
- Protocol 104: Low Participant Risk;
Match each research protocol to its specific oversight stream classification.
- Protocol 101 (Medium Risk; )Full Board Audit (triggered primarily by )
- Protocol 102 (High Risk; )Full Board Audit (triggered primarily by High Participant Risk)
- Protocol 103 (Low Risk; )Expedited Committee Review (triggered by )
- Protocol 104 (Low Risk; )Administrative Exemption (triggered by Low Risk and )